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ABSTRACT: In an increasingly complex information society, demands for cognitive functioning are growing steadily. In recent
years, numerous strategies to augment brain function have been proposed. Evidence for their eﬃcacy (or lack thereof) and side
eﬀects has prompted discussions about ethical, societal, and medical implications. In the public debate, cognitive enhancement
is often seen as a monolithic phenomenon. On a closer look, however, cognitive enhancement turns out to be a multifaceted
concept: There is not one cognitive enhancer that augments brain function per se, but a great variety of interventions that can
be clustered into biochemical, physical, and behavioral enhancement strategies. These cognitive enhancers diﬀer in their mode
of action, the cognitive domain they target, the time scale they work on, their availability and side eﬀects, and how they
diﬀerentially aﬀect diﬀerent groups of subjects. Here we disentangle the dimensions of cognitive enhancement, review
prominent examples of cognitive enhancers that diﬀer across these dimensions, and thereby provide a framework for both
theoretical discussions and empirical research.
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1. INTRODUCTION
An increasingly complex world exerts increasing demands on
cognitive functionsfunctions that evolved for a fundamentally
diﬀerent environment. Daily life in an information society and a
postindustrial economy require cognitive skills that have to be
acquired through slow, eﬀortful, and expensive processes of
education and training. Likewise, these skills can become
obsolete as the world changes ever faster or be lost by the
processes of aging. People also vary in their mental abilities,
allowing them to acquire certain skills more quickly or slower,
which may have signiﬁcant eﬀects on life outcomes. Strategies to
improve the acquisition and maintenance of cognitive skills are
thus increasingly important on both an individual and societal
level. These challenges of our times have fostered the
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exploration of strategies to enhance human brain function.
While people have since time immemorial sought to improve
their performance, the present era is unique in that not only the
challenges are growing rapidly but so are technologies that
promise to meet them. Just like the hacking culture in the realm
of computer software and hardware, an increasing number of
individuals experiment with strategies to creatively overcome
the natural limitations of human cognitive capacityin other
words, to hack brain function. This development has led to both
enthusiasm and dread, as observers have sharply diﬀering
intuitions about the feasibility, utility, risks, and eventual impact
of enhancement technologies on the world.
One reason for the often polarized debates has been the lack
of hard evidence. Without empirical ﬁndings, it is easy to
maintain any position, as well as regard opponents as having
unfounded views. A further essential source of disagreement and
theoretical confusion is a tendency to view enhancement as a
unitary phenomenon to be judged as a whole, rather than as a
broad set of techniques with important diﬀerences and diverging
implications. Only on the basis of a clear picture on how a
particular enhancement strategy might aﬀect speciﬁc cognitive
processes in speciﬁc populations, along with side eﬀects and
costs to be expected, an informed theoretical debate can evolve
and a promising empirical research designs to test the strategy
can be proposed. In the following, we aim to elucidate seven
essential dimension of cognitive enhancement, namely, (a) its
mode of action, (b) the cognitive domain targeted, (c) personal
factors, (d) its time scale, (e) side eﬀects, (f) availability, and (g)
social acceptance (see Figure 1). Further, we will review
empirical data of prominent examples of cognitive enhancers
that diﬀer across these dimensions and thereby illustrate some of
their nuanced implications. The aim of our Review is to sketch a
general framework that will foster both theoretical discussions
and empirical research.
2. MODE OF ACTION
A widely cited deﬁnition characterizes enhancement as
interventions in humans that aim to improve mental functioning
beyond what is necessary to sustain or restore good health.1
While the current bioethical debate on cognitive enhancement is
strongly focused on pharmacological ways of enhancement,
improving mental capabilities also by nonpharmacological
means has to be considered as cognitive enhancement proper
according to the given characterization. We have reviewed
elsewhere the eﬃcacy of a number of nonpharmacological
enhancers.2,3 To systematize the vast variety of diﬀerent
approaches of cognitive enhancement, we suggest clustering
enhancement strategies into three major areas according to their
main mode of action. Even though boundaries are not strict,
most cognitive enhancement strategies can be considered to
work as either biochemical, physical, or behavioral interventions
(Figure 2). In the following, we will give an overview on the
diﬀerent cognitive enhancement strategies within these clusters.
2.1. Biochemical Strategies. The prototypical cognitive
enhancers addressed in the public debate are biochemical
agents. However, biochemical interventions are not restricted to
pharmaceutical “smart drugs”. Also application of ordinary
substances such as oxygen has been shown to increase, e.g.,
memory processes4,5 and neural activation in memory-related
brain regions.6
Biochemical enhancers with the longest tradition in human
history are strategies to make use of certain nutritional
components. Most widely used are probably glucose7 and
caﬀeine,8,9 which both have demonstrated cognition-enhancing
eﬀects in numerous studies. In addition to coﬀee, other
beverages from caﬀeine-bearing plants such as guarana have
shown to enhance cognition.10 While the noncaﬀeine
components in caﬀeine-bearing plants might exert independent
eﬀects on cognition,11 it has been doubted that industrially
designed drinks contain cognitive enhancing components that
go beyond caﬀeine, glucose, or guarana extract.12 Further
nutritional components with some evidence for cognitive
enhancing eﬀects are ﬂavonoids, e.g., in cocoa,13,14 curry powder
(most likely due to the curcumin that it contains,15,16 folic
acid,17 or omega-3 fatty acids.18 Besides speciﬁc dietary
supplements, also the absence of food might enhance cognition:
some evidence has been reported that fasting and general caloric
restriction might improve memory in elderly individuals.19,20
Also certain traditional natural remedies have been discussed
as cognitive enhancers: besides herbs that also grow in Western
regions such as salvia,21 particularly traditional Chinese and
Figure 1. Cognitive enhancement interventions diﬀer across several
interdependent dimensions.
Figure 2. Cognitive enhancement interventions diﬀerent in their mode
of actions.
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Indian herbal medicines such as Bacopa monnieri have been
ascribed with cognitive enhancing eﬀects.22,23 However, with
ginseng and ginkgo biloba, themost prominent examples of such
traditional Asian herbal remedies so far have failed to
consistently show positive eﬀects on cognitive functions in
healthy individuals.24,25
A further biochemical intervention with a long history
concerns drugs that are being used recreationally and that
have demonstrated the potential to enhance certain cognitive
functions. For example, nicotine improves attention and
memory,26−28 and even alcohol, despite impairing many
cognitive functions, might enhance others such as creative
processes29,30 or, retroactively, memory.31
Pharmaceuticals are in particular by the public regarded as
prototypical cognitive enhancers: synthetic stimulants such as
amphetamine, methylphenidate, or modaﬁnil, or antidementia
drugs such as acetylcholinesterase inhibitors and memantine are
at the core of public debate on cognitive enhancement.
However, evidence for their eﬃcacy for augmenting brain
function and cognition in healthy subjects is often markedly
lower than assumed in theoretical discussions.32−37 Importantly,
the lack of an objective eﬀect on cognition can be accompanied
by a considerable placebo eﬀect: for example, users who believed
to have received mixed-amphetamine salts subjectively rated
themselves as performing better and even show minor objective
performance increases, independent of actual medication
state.38
While pharmacological enhancers are typically designed to
aﬀect or mimic certain neurotransmitters, also neural signaling
molecules themselves such as adrenaline,39 GABA,40 glucocorti-
coids,41 ovarian hormones,42 and diﬀerent neuropeptides43−45
have been suggested as cognitive enhancers.
A further biochemical strategy for cognitive enhancement
consists of genetic modiﬁcations, which have been demon-
strated to augment several learning and memory processes in
animal models.46−51 Although progress has also been made in
elucidating the genetic basis of cognitive traits in humans,52
genetic modiﬁcations in humans still have to be considered as
future strategies rather than currently available enhancement
options.
2.2. Physical Strategies. The current most widely
discussed physical strategies for cognitive enhancement include
a number of brain stimulation technologies. Whereas the
cognition enhancing eﬀects of invasive methods such as deep
brain stimulation53,54 are restricted to subjects with pathological
conditions, several forms of allegedly noninvasive stimulation
strategies are increasingly used on healthy subjects, among them
electrical stimulation methods such transcranial direct current
stimulation (tDCS55), transcranial alternating current stimula-
tion (tACS56), transcranial random noise stimulation (tRNS57),
transcranial pulsed current stimulation (tPCS58,59), trans-
cutaneous vagus nerve stimulation (tVNS60), or median nerve
stimulation (MNS61). Details of the stimulation procedures
appear to be crucial: commercial do-it-yourself electrical brain
stimulators might impair rather than enhance cognition,62 and
systematic reviews have shed doubt on a clear and simple
enhancing eﬀect of electrical brain stimulation on diﬀerent
cognitive domains also under controlled laboratory condi-
tions.63,64 Recent studies have even questioned if some of the
most commonly used setups for electrical brain stimulation have
neurophysiologically meaningful eﬀects at all.65−68 On this
background, the development of noninvasive deep brain
stimulation via temporally interfering electric ﬁelds might
provide a more systematic and targeted mechanism compared
to the currently used approaches.68
Besides electrical stimulation methods, also for transcranial
magnetic stimulation (TMS69), optical stimulation with lasers,70
and several forms of acoustic stimulation, such as transcranial
focused ultrasound stimulation,71 binaural beats,72,73 or auditory
stimulation of the EEG theta rhythm74 or sleep EEG slow
oscillations,75 a potential for cognitive enhancement has been
reported.
Physical enhancement methods that target brain processes
more indirectly include whole body vibrations,76 stochastic
resonance motor control improvement,77,78 and several forms of
neurofeedback,79 with, e.g., EEG neurofeedback in the upper
alpha band enhancing memory,80 working memory,81 and
visuospatial skills.82 Besides classical neurofeedback training
that involves unspeciﬁc but active eﬀort of the subject, also
neurofeedback interventions that automatically feedback low
energy currents in response to EEG activity have been
developed, thereby allowing the subject to receive the training
procedure passively.83 Recently, the use of fMRI neurofeedback,
utilizing multivariate pattern analysis, has shown the potential to
increase sustained attention84 or visuospatial memory.85
Finally, humans have always deployed physical tools to assist
cognitive functioning. In current developments that converge
minds and machines, these tools become more closely
integrated with the person.86 Crowdfunding or biohacking
communities have developed numerous novel technical devices
to increase cognitive functions transiently with, e.g., wearable
electronic memory aids or augmented reality gadgets,87,88 or
more permanently as in the case of cognition enhancing or
extending bodily implants.88,89 Neural implants or prosthetics
have progressed; in controlled laboratory settings, implants
could facilitate humanmemory.90 In addition, Brain−Computer
Interfaces connect the central nervous system with computers
through wearable or implanted electrodes and may aﬀord a
range of applications that enhance cognitive functions or joint
outputs of minds coupled with machines.91,92
2.3. Behavioral Strategies. Although not commonly
recognized as such by the public, cognitive enhancers with the
most wide use and longest history are probably behavioral
strategies: a rapidly growing body of evidence shows that
everyday activities such as sleep93 or physical exercise94−96
improve cognitive functioning. Also well-established cultural
activities such as musical training,97,98 dancing,99 or learning a
second language100 have been demonstrated to enhance
cognition beyond the speciﬁcally trained skills.
In addition to these natural and cultural standard activities,
several behavioral strategies have been developed to enhance
certain brain functions intentionally. Two strategies that reach
back to ancient times are mnemonic techniques to enhance
learning and memory101,102 and meditation training to enhance
attention processes and mindfulness.103,104 In contrast,
commercial video games105,106 and customized computer
trainings107 represent historically very recent developments
that are targeted to enhance speciﬁc cognitive capacities and
skills. In contrast to several years of enthusiasm and widespread
commercial application, however, more recent controlled
studies and meta-analyses have shed some doubt on the eﬃcacy
of computerized brain training programs,108 particularly criticiz-
ing claims of “far transfer” of training gains to cognitive domains
considerably diﬀerent from the speciﬁcally trained skills.109,110
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3. COGNITIVE DOMAIN
The human mind is not a monolithic entity, but consists of a
broad variety of cognitive functions. Not surprisingly, no single
cognitive enhancer augments every cognitive function. Instead,
most cognitive enhancers have speciﬁc proﬁles regarding their
eﬃcacy for diﬀerent cognitive domains. Memory is, e.g., strongly
enhanced by mnemonic strategies, but not by meditation;
attention, in turn, is strongly enhanced by meditation training,
but not training in mnemonic strategies.101,103,104 Sleep, in
contrast, enhances both cognitive capacities.111,112 Some
computerized cognitive trainings have been found to enhance
memory, processing speed and visuospatial skills, but not
executive functions or attention.107 It is currently highly debated
in how far speciﬁc training strategies exert transfer eﬀects also to
nontrained cognitive domains.113
Diﬀerent cognitive tasks require diﬀerent optimal levels of
receptor activation, thus requiring diﬀerent doses of pharmaco-
logical enhancers targeting the respective neurotransmitter
system depending on the cognitive domain targeted.114 Of note,
eﬀects of pharmacological enhancement on diﬀerent cognitive
domains might even diﬀer depending on the cognitive test
battery used, illustrating the fragility of the respective eﬀects.115
Some interventions might even enhance one but impair
another cognitive domain: Intranasal application of oxytocin has
been shown to enhance social cognition and cognitive ﬂexibility
but impairs long-term memory.116,117 Methylphenidate im-
proves the ability to resist distraction but impairs cognitive
ﬂexibility.118 Computerized working memory training has been
reported to enhance workingmemory, reasoning, and arithmetic
abilities; however, it might deteriorate creativity.119 Also for
amphetamines and modaﬁnil, potential impairments on
creativity are discussed besides their enhancing eﬀects on
other domains.120,34 In contrast, alcohol might enhance creative
processes while impairing most other cognitive functions.29
The costs and beneﬁts of a single cognitive enhancer might
even change through slight changes in the application process:
for example, electrical stimulation of posterior brain regions was
found to facilitate numerical learning, whereas automaticity for
the learned material was impaired. In contrast, stimulation on
frontal brain regions impaired the learning process, whereas
automaticity for the learned material was enhanced.121 Brain
stimulation has thus been suggested to be a zero-sum game, with
costs in some cognitive functions always being paid for gains in
others.122 This implies that enhancement may have to be tuned
to the task at hand, in order to focus on the currently most
important cognitive demands.
4. PERSONAL FACTORS
The eﬃcacy of cognitive enhancers does not only diﬀer for
diﬀerent cognitive domains, but also for diﬀerent users. An
important factor in this regard are the cognitive skills of the
individual prior to the enhancement intervention. Many
pharmaceuticals, including amphetamine,123 modaﬁnil, and
methylphenidate,124 work mainly in individuals with low
baseline performance. In some cases, even impairments in
individuals with higher performance at baseline have been
reported, e.g., in the case of amphetamine,125 methylpheni-
date,124 nicotine,27 or acute choline supplementation.126 The
phenomenon of enhanced cognition in individuals with low
baseline performance and impairments in those with high
baseline performance can be explained by the classical inverted
U-model,127,128 where performance is optimal at intermediate
levels of the targeted neurochemicals and impaired at levels that
are either too low or too high.129−131 For some drugs such as
methylphenidate, enhancement dependency on the baseline
might even diﬀer between cognitive functions, with performance
in speciﬁc tasks being improved in low, while impaired in high,
performers,124 but showing the opposite pattern for other
tasks.132
The baseline-dependency of cognitive enhancement is not
restricted to pharmaceuticals: also in the case of video games,133
cognitive training,134 or brain stimulation,135,136 individuals
starting at a lower baseline performance beneﬁt more than those
with an already high performance at baseline. In contrast, sleep
appears to improvememory particularly in subjects with a higher
baseline performance of memory,137 working memory138 or
intelligence.139 Also mnemonic training appears to work
particularly well in individuals with a higher cognitive baseline
performance.140 This has been interpreted in terms of an
ampliﬁcation model, in which high baseline performance and
cognitive enhancement interventions show synergistic ef-
fects.141
Cognitive enhancers can also aﬀect individuals diﬀerently
depending on basic biological, psychological, or social factors.
For example, eﬀects of training interventions on selective
attention can depend on the genotype of the trainee;142 eﬀects of
methylphenidate on creativity can depend on personality
characteristics;143 the cognition enhancing eﬀects of sleep144
or video games145 are modulated by gender. In turn, such
modulations of enhancement eﬀects might reduce existing
diﬀerences in cognitive proﬁles, as seen, e.g., in action video
game training, that have the potential to eliminate gender
diﬀerences in spatial attention and decrease the gender disparity
in mental rotation ability.146 Also the hormonal status of
subjects aﬀects how strongly they proﬁt, e.g., from sleep144−148
or brain stimulation.149 Caﬀeine enhances working memory
particularly in extraverted individuals,150 and memory enhance-
ment through sleep151 or mnemonic training140 has been
reported to depend on the age of subjects. Health status aﬀects
how much users beneﬁt from diﬀerent kinds of cognitive
enhancers, including pharmaceuticals,3 mnemonics,152 or
sleep.153−156 Finally, also socioenvironmental factors such as
social resources, parental occupation, or family composition can
modulate cognitive enhancement interventions, e.g., with
cognitive training programs.157
5. TIME SCALE
Interventions for cognitive enhancement diﬀer in the speciﬁc
time scale they require to achieve their aims. The prototypical
“smart pill” discussed in popular accounts of cognitive
enhancement needs practically no preparation time, exerts its
eﬀects within seconds or minutes, and lasts for several hours.
While this is close to reality in the case of some pharmacological
enhancers, the temporal pattern of most other enhancement
strategies diﬀers strongly from these time scales. In particular,
the time needed for application and the duration of their eﬀects
markedly varies between enhancement interventions.
Most pharmacological enhancers can be applied quickly and
without further preparation; however, some drugs such as
acetylcholinesterase inhibitors or memantine are thought to
require longer periods of intake to be eﬀective.33 Also some
nutritional enhancers such as glucose and caﬀeine exert their
eﬀects rather quickly, whereas other nutritional supplements
have to be taken over extended periods to show an impact on
cognition.158,18 Obviously, behavioral strategies like sleep,
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exercise, video games ormnemonic training need hours or weeks
to robustly enhance cognition. Some eﬀects of meditation might
even take years of training.159 For brain stimulation methods,
both immediate eﬀects of acute stimulation, but also more
delayed eﬀects after repeated stimulation haven been
observed.55,69 Technological gadgets or implants need some
preparation to be installed and accommodated to, however then
exert their cognition augmenting eﬀects on demand.
Enhancing eﬀects of most quickly acting pharmacological or
nutritional cognitive enhancers also wear oﬀ rather rapidly. In
contrast to such transient eﬀects, interventions such as brain
stimulation,160,161,57 sleep,162 mnemonic strategies163 or genetic
modiﬁcations46 have the potential for long-term up to chronic
enhancement. However, in the latter case, the reversibility of the
eﬀects (and side eﬀects) of an enhancement intervention might
be a further aspect to be considered.
Interventions can also diﬀer regarding the time point of
application relative to the situation when enhanced cognitive
performance is needed. For example, application of stress
hormones such as cortisol or adrenaline before or after memory
encoding enhances memory, whereas application before
retrieval impairs memory;41 benzodiazepines impair memory
when given before and enhance memory when given after
encoding;164 in contrast, caﬀeine before learning enhances
memory under certain conditions but might impair memory
when consumed afterward.165,9 Mnemonic strategies on the
other hand work solely when taught/applied before/during
encoding, but can hardly be applied afterward.
Finally, some interventions can also inﬂuence the timing of
cognitive performance itself: stimulants such as methylpheni-
date, modaﬁnil, and caﬀeine might increase the time subjects
take to perform a given task, with impairing eﬀects under time
pressure and potentially enhancing eﬀects in the absence of
temporal constraints.166
6. SIDE EFFECTS
The pharmaceutical platitude that there is no eﬀect without side
eﬀects holds true also for many nonpharmacological enhance-
ment interventions. It appears obvious that cognitive enhancers
diﬀer in the severity and form of side eﬀects: prima facie, deep
brain stimulation or implants have higher risks for side eﬀects
than sleep or cognitive training. However, also more indirect
enhancement strategies such as neurofeedback potentially bear
the risk of side eﬀects up to inducing epileptiform activity,167
and even gentle intervention such as meditation training might
exert negative eﬀects on speciﬁc cognitive domains: a negative
relationship between mindfulness and implicit learning168,169
and an increased susceptibility to false memory formation after
mindfulness meditation170 have been observed. Here, the
intended training goal of nonjudgemental mindfulness opposes
tasks where either a more critical or automatic mindset was
needed. Further examples of side eﬀects intrinsically associated
with the enhancement goal are trade-oﬀs between stability vs
ﬂexible updating of memory systems:129 memories can also
become “too stable” due to a memory enhancement
intervention, as observed, e.g., for the anti-obesity drug
rimonabant.171
It has been suggested to diﬀerentiate enhancement strategies
according to their level of invasiveness.172,173 However, while
invasiveness has a more or less deﬁnite meaning in its original
medical context, physically breaching the skin or entering the
body deeply through an external oriﬁce,174 it is diﬃcult to
determine the level of invasiveness in the context of cognitive
enhancement. Both nutritional supplements and pharmaceut-
icals enter the body, and thus could be considered invasive in a
narrow medical sense, as might be certain forms of physical
exercise due to the risk of bruises or scratches as common, e.g., in
martial arts or a hike through the woods. Brain stimulation that
does not break the skin would, by contrast, be classiﬁed as
noninvasive. This taxonomy can be disputed for good
reasons.175 Besides known risks of these stimulation methods
such as scalp burns from tDCS or seizures from TMS, the
“known unknowns” have been suggested to pose potentially
even greater risks: potential build-up eﬀects across multiple
sessions or in sensitive nontarget areas.176 Of note, only few
neuroscientists use brain stimulation on themselves for cognitive
enhancement.176 Given the still unclear risks and side eﬀects of
do-it-yourself brain stimulation use, it has been proposed to
extend existing medical device legislation to cover also
nonpharmacological and in particular physically acting cognitive
enhancement devices.177,178 In contrast to strict medical
deﬁnitions, the more intuitively assessed level of invasiveness
of an intervention often seems to depend on familiarity and
cultural traditions. This leads to the Western attitude according
to which changing one’s diet or performing exercise appears less
invasive than taking pharmaceuticals or applying brain
stimulation, independent of their actual eﬀects on health.
Related to the time scale dimension, side eﬀects of short- vs
long-term use of cognitive enhancers can be diﬀerentiated. For
example, while side eﬀects for the acute use of methylphenidate
include increased heart rate, headache, anxiety, nervousness,
dizziness, drowsiness, and insomnia, in the case of long-term use
side eﬀects such as abnormal prefrontal brain function and
impaired plasticity have been reported.179,180 Also addiction is a
well-known side eﬀect for the long-term use of pharmacological
enhancers, which is particularly detrimental to the aim of
enhancement if combined with tolerance eﬀects such that larger
doses are needed to achieve the same eﬀect (or prevent
impairing withdrawal eﬀects). Also behavioral addictions have
been observed, e.g., physical exercise181 or the use of
technological gadgets.182
A somewhat nonobvious negative eﬀect of some cognitive
enhancers is their illusional eﬃcacy: users sometimes believe
their performance to be enhanced by amphetamine in absence of
any veriﬁed and objectively visible enhancing eﬀects, even if
administered in a double blind manner.183,184,38 This is
particularly counterproductive in cases of already high-
functioning individuals whose cognitive capabilities might be
impaired rather than enhanced by amphetamine.125,184 Also for
caﬀeine, under certain conditions higher subjectively perceived
mental energy in the absence of objectively enhancing eﬀects
have been observed.185 The often subtle eﬀects of enhancers can
be hidden or ampliﬁed by placebo eﬀects.
7. AVAILABILITY
Cognitive enhancers diﬀer in at least three aspects of availability:
legal status, cost, and application time. In terms of legal
regulation, diﬀerent enhancement methods are regulated by
sometimes drastically varying frameworks. Pharmaceuticals, for
instance, are regulated by strict international control regimes
that eﬀectively prohibit nontherapeutic uses or by more lenient
domestic drug laws. Brain-stimulation methods, by contrast, fall
under medical device regulations, pertaining to basic safety
standards in terms but not proscribing the uses to which they
might be put.177,178 Behavioral strategies are usually not
regulated at all. The regulatory landscape is thus vast and
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possibly incoherent (for a review, see ref 186). Besides practical
hurdles to the acquisition of illicit drugs for cognitive
enhancement, the legal status appears to aﬀect the motivation
of users to decide which cognitive enhancers to take.166
A common ethical argument in the enhancement debate
concerns distributive justice: also legally available enhancers
come with cost barriers, restricting individuals of low socio-
economic status from access.187 A main factor in the costs of
cognitive enhancers is their patentability, which is not restricted
to pharmaceuticals.188 However, in particular, behavioral
enhancement strategies are typically not subject to patentability
or other cost-driving factors: sleep, exercise, meditation, or
training in mnemonic strategies are largely free of cost and, thus,
in contrast to pharmaceuticals or technological strategies, are
available independent from the ﬁnancial background of the user.
On the other hand, these behavioral strategies require some time
and eﬀort: the 24/7 working manager as the cliche ́ user of
cognitive enhancement drugs might have the ﬁnancial means to
aﬀord quickly taking his expensive smart pill between two
meetings, but might be unable or unwilling to spend extended
periods of time with sleep, meditation, or mnemonic training.
8. SOCIAL ACCEPTANCE
Largely independent from their speciﬁc enhancing eﬀects on
diﬀerent cognitive capacities, social acceptance of cognitive
enhancement interventions diﬀers strongly depending on
traditions, their perceived naturalness, and the perceived
directness of their mode of action. Enhancement interventions
with a tradition of thousands of years such as meditation and
nutrition are typically much better accepted thanmany currently
debated enhancement strategies such as brain stimulation and
pharmaceuticals.189 Also more “natural” interventions such as
sleep or exercise are seen in a more positive light compared to
technological innovations.190 Moreover, in how far the mode of
action is perceived as psychologically mediated or more
biologically direct, aﬀecting the brain indirectly through the
senses or more directly through the cranium or metabolism,
often plays a role for their social acceptance: if an enhancement
intervention such as intense cognitive or physical training
requires extended eﬀorts or is seen as a quick and eﬀortless
shortcut to the same goal as in the case of smart pills or brain
stimulation touches diﬀerent intuitions about human virtues and
is thus valuated diﬀerently. Even though views based on such
purely intuitive aspects of tradition, naturalness, or directness
often rely on cognitive biases rather than rational argument,191 a
negative social perception for whatever reason might generate
indirect psychological costs for users, which in turn might
inﬂuence also rational evaluations of the respective enhance-
ment intervention.192
Accordingly, one of the central points in the ethical
controversy revolves around the question of whether enhance-
ment strategies only relevantly diﬀer with respect to their
outcomes, i.e., their beneﬁts and side eﬀects,193 or also with
respect to their mode of operation.194 Some argue that the
relevant ethical distinction runs along the lines of enhancements
that are active, in the sense of requiring participation, and those
that work on persons more passively.195
Not surprisingly, diﬀerent views on cognitive enhancement
prevail in diﬀerent (sub)cultures, with, e.g., a more positive view
on enhancement interventions in Asia196 or in younger
populations.197 Empirical studies on attitudes toward cognitive
enhancement interventions found medical safety, coercion, and
fairness the most common concerns, with nonusers displaying
more concerns regarding medical safety and fairness than
users.198 Sometimes readily available substances for cognitive
enhancement such as caﬀeine, energy drinks, or herbal drugs are
dubbed “soft enhancers”;199 however, considering that prohib-
ition of substances is not only based on their potential harm, but
also on historical circumstances, this diﬀerentiation between soft
and hard enhancers appears questionable.
A further aspect that determines the social acceptance of
cognitive enhancement is the aim of the given intervention.
Taken by face value, the term cognitive enhancement denotes any
action or intervention that improves cognitive capacities,
independent from the speciﬁc aim of this improvement. The
use of the term in the empirical, philosophical, and sociopolitical
literature, however, varies with regard of the speciﬁc aim of
enhancement interventions: people appear to be more tolerant
toward enhancement of traits considered less fundamental to
self-identity,200 and also more tolerant toward enhancement in
individuals with cognitive impairments or low performance
baselines compared to enhancement of normal or high
achievers.201,202 At least four diﬀerent aims can be identiﬁed,
each leading to diﬀerent research strategies and diﬀerent ethical
evaluations of existing or potential enhancement strategies.203
The least problematic concept of cognitive enhancement targets
those everyday medical or psychological interventions that are
meant to treat pathological deﬁciencies. Closely related are
those cognitive enhancement interventions that aim to prevent
or attenuate cognitive decline that is associated also with healthy
aging.204 Slightly less accepted appear to be those enhancement
strategies that aim to improve cognition in completely healthy
individuals, but still clearly stay within the normal limits of
cognition. The probably most widely used and ethically most
controversial concept of cognitive enhancement aims at the
augmentation of cognitive capacities beyond normal function, as
is represented in the cliche ́ of high-functioning students or
managers trying to further improve their performance by taking
smart pills.
Besides these diﬀerentiations between enhancement of
impaired vs healthy cognition, another diﬀerence in the aims
of cognitive enhancement touches the ultimate deed of the
enhancement intervention: due to the central role of cognitive
capacities in deﬁning humans as a species, it is tempting to
consider the improvement of these deﬁning human capacities as
a value in itself. However, most philosophical or religious
approaches do not center on objective cognitive performance
markers, but propose values only indirectly related to cognitive
performance such as living a happier or more meaningful life in
general. In this light, human enhancement in more general terms
does not need to aim for individual cognitive or neural processes,
but can also be achieved by sociopolitical reforms targeted at the
population level.205,206
9. CONCLUSIONS
Cognitive enhancement clearly is a multidimensional endeavor.
However, not every dimension is important for every theoretical
or empirical research question. For example, many empirical
researchers of cognitive enhancement are primarily interested in
the understanding of the neurobiological and psychological
mechanisms underlying cognitive functions.207 For this aim, the
availability and social acceptance dimensions are largely
irrelevant. In contrast, many theorists are interested in the
social and ethical implications of cognitive enhancement,208
where these dimensions might be of prime importance. Also side
eﬀects and temporal factors might be of secondary importance
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to empirical researchers with an interest in the neural
mechanisms of certain cognitive processes, whereas these
would be highly relevant for users who ponder the question
which cognitive enhancement strategy to choose for a certain
aim. When comparing diﬀerent cognitive enhancement
strategies, diﬀerent dimensions might thus be diﬀerently
weighed or completely ignored, depending on the aim of the
comparison.
Up until now, direct comparisons between cognitive
enhancement strategies with radically diﬀerent modes of actions
have rarely been made (but see, e.g., ref 165), and more
comprehensive comparisons across dimensions might be
diﬃcult: practical issues of information availability from the
diﬀerent dimensions aside, interventions typically diﬀer on
diﬀerent dimensions and are thus diﬃcult to compare globally.
In addition, multiple interactions between diﬀerent enhancers
exist, which further complicates the situation. Interactions have
been reported, e.g., for glucose and caﬀeine,209 diet and
exercise,210 exercise and working memory training,211 video
games and sleep,212 video games and brain stimulation,213
exercise and brain stimulation,214 and brain stimulation and
sleep.215,216 Also diﬀerent dimensions discussed here can
interact in multiple ways, as, e.g., computerized cognitive
training can diﬀerentially enhance diﬀerent cognitive processes
depending on personal factors such as age;217 and social
acceptance of diﬀerent enhancement strategies depends on both
the baseline performance of users and the cognitive domain
targeted.200,201
Despiteor because ofthese complexities, in our opinion,
both theoretical discussions and empirical research would
strongly beneﬁt from a more diﬀerentiated approach. Speciﬁc
research questions might require the emphasis on some
dimensions of cognitive enhancement over others, and for
some research questions some dimensions might be entirely
irrelevant. Nevertheless, keeping in mind that cognitive
enhancement is not a monolithic phenomenon will help to
solve and avoid a number of confusions and disagreements that
are still present in the public debate on cognitive enhancement.
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